Journal of Nuclear Medicine
The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly …
JNM Information for Authors | Journal of Nuclear Medicine
Editorial Policy. The Journal of Nuclear Medicine (JNM) publishes material of interest to practitioners and scientists in the fields of nuclear medicine and molecular imaging.Proffered articles describing original laboratory or clinical investigations, brief communications, and letters to the editor will be considered for publication.
About Us | Journal of Nuclear Medicine
The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical and basic science investigations, continuing education articles, state-of-the-art reviews, employment opportunities, and updates on rapidly …
Published Ahead of Print | Journal of Nuclear Medicine
2024年12月12日 · PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177 Lu-PSMA-617: Importance of 18 F-FDG–Avid Discordant Findings
Archive of all online content | Journal of Nuclear Medicine
2024年12月1日 · Immuno-PET/CT Imaging of Trop2 with [18 F]AlF-RESCA-T4 Differentiates Lung Cancer from Inflammation
Table of Contents — November 01, 2024, 65 (11) | Journal of …
Efficacy and Toxicity of [177 Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data
Table of Contents — May 01, 2024, 65 (5) - Journal of Nuclear …
2024年5月1日 · Optimal [18 F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial
The Future of Nuclear Medicine | Journal of Nuclear Medicine
2023年9月1日 · As I noted in the Wagner Lecture at this year’s Society of Nuclear Medicine and Molecular Imaging Annual Meeting, nuclear medicine (NM) is an ever-changing and rapidly advancing practice in which clinical advances are driven by closely allied efforts in physics, chemistry, biology, and translational research relevant to radiopharmaceutical imaging and …
Archive of all online content | Journal of Nuclear Medicine
2024年12月1日 · The Journal of Nuclear Medicine archive contains all online content for practitioners and scientists in nuclear medicine and molecular imaging.
Help | Journal of Nuclear Medicine
Common Answers. How to subscribe: Details on subscription options, rates, and single issue purchases are found on the SNMMI site. How to join: Want to be a member of SNMMI | Society of Nuclear Medicine and Molecular Imaging?Visit SNMMI.org to register.. Continuing Education: Activities for JNM and JNMT Continuing Education articles are located at the SNMMI Learning …